Provided herein are methods of determining a location of one or more analytes of interest in a cancer sample. Also provided herein are methods of detecting expression of one or more analytes in a cancer (e.g., breast cancer) sample. Further provided are methods of diagnosing and treating ...
Described herein is the use of Agouti Signaling Protein (ASIP), in addition to certain other melanocortin signaling network (MSN) genes, as prognostic and predictive biomarkers for the progression of breast cancer. In particular, the novel biomarkers can be used to determine if a female breast ...
以乳腺癌为例,在Search Tumor Type栏输入或下拉选择Breast cancer,回车可得到检索结果,共有21个基因及对应的37种药物注释信息,其中Level1~4包含的基因分别为6、2、4和11个,LevelR1~2包含的基因分别为0和2个。页面下拉可以看到不同级别对应的基因名称、突变类型和相关药物。 以ERS1为例,点击进入查看详情,首先可以...
The present invention provides protein-based biomarkers and biomarker combinations that are useful in qualifying breast cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as breast cancer or non-breast cancer. The biomarkers can be det...
Breast cancer heterogeneity represents a major hurdle to improve patient survival. Notwithstanding its potential curability due to the availability of treatment modalities that are effective in the presence of favourable clinical or patho-biologic features, there is still a great deal of controversy in ...
Breast cancer is the second most frequent cancer in the world. It is a heterogeneous disease and the leading cause of cancer mortality in women. Advances in molecular technologies allowed for the identification of new and more specifics biomarkers for breast cancer diagnosis, prognosis, and risk ...
breastcancerscreen-i ng.【Key w ord】Breast neopl asm s;M ass screeni ng;Bi ol og-i cal m arkers目前,乳腺癌筛查及诊断方法如自我检查、彩超、钼靶、针吸细胞学检查等效果不理想uJ 。因此,寻找新的、可靠的筛查手段对于发现早期乳腺癌具有非常重要的意义。生物标记物是生理或病理过程中可供客观测定和...
Breast cancer stem cells (BCSCs) are the main player in the aggressiveness of different tumors and also, these cells are the main challenge in cancer treatment. Moreover, the major obstacle to achieve an effective treatment is resistance to therapies. There are various types of treatment for ...
This consensus statement revises and updates the recommendations for biomarkers use in the diagnosis and treatment of breast cancer, and is a joint initiative of the Spanish Society of Medical Oncology and the Spanish Society of Pathology. This expert group recommends determining in all cases of bre...
Prognostic role of pre-diagnostic circulating inflammatory biomarkers in breast cancer survival: evidence from the EPIC cohort study Carlota Castro-Espin ,Manon Cairat &Laure Dossus Article 24 September 2024|Open Access Association of metabolic obesity phenotypes with risk of overall and site-specific ...